Teradyne director sells 167 shares under 10b5-1 plan
Teradyne, Inc. director Mercedes Johnson reported an open-market sale of 167 shares of common stock at $369.74 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Teradyne, Inc. director Mercedes Johnson reported an open-market sale of 167 shares of common stock at $369.74 per share. The sale occurred on June 2, 2026 and was made pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2026. After this transaction, Johnson directly holds 6,864 Teradyne shares and indirectly holds 1,876 shares through The Mercedes Johnson Trust UAD 07/23/04, where she is trustee and sole beneficiary.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 167 | $369.74 | $62K |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on March 4, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2. Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
Key Figures
Key Terms
Rule 10b5-1 regulatory
open-market sale financial
Form 4 regulatory
beneficiary financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Teradyne (TER) director Mercedes Johnson report?
How are Mercedes Johnson’s indirect Teradyne (TER) holdings structured?
AI-generated analysis. How Rhea-AI works. Not financial advice.